As the Bloc Québécois pushes for broader OAS payments, concerns rise over the impact on disability benefits
The report shows how businesses can harness the disability market through experience-focused strategies
Gene therapy and corticoid steroids are just a few treatment options available for those with Duchenne
A GSK survey shows many older Canadians lack knowledge about RSV, a major cause of respiratory illness
Experts warn the new CDB may become an indirect transfer to provinces without changes to regulations
Advocates express disappointment as Canada Disability Benefit's impact on poverty falls short of promises
